GASTROINTESTINAL NEOPLASMS
Clinical trials for GASTROINTESTINAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL NEOPLASMS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to keep cancer treatment on track: drug trial targets Chemotherapy's dangerous side effect
Disease control OngoingThis study is testing if a drug called avatrombopag can help patients with gastrointestinal cancers who develop persistently low platelet counts from their chemotherapy. Low platelets can cause dangerous bleeding and force doctors to delay or reduce chemotherapy doses. About 60 p…
Matched conditions: GASTROINTESTINAL NEOPLASMS
Phase: PHASE2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Major global trial aims to boost survival for stomach cancer with new drug combo
Disease control OngoingThis large, late-stage study is testing whether adding an immunotherapy drug (durvalumab) to standard chemotherapy, given both before and after surgery, can help patients with operable stomach or gastroesophageal junction cancer live longer without their cancer returning. It comp…
Matched conditions: GASTROINTESTINAL NEOPLASMS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Doctors test if chemo slows rare 'Jelly Belly' cancer
Disease control OngoingThis study aims to find out if standard chemotherapy drugs can help control the growth of a rare type of appendix cancer that spreads inside the abdomen. It will enroll 30 patients who are not candidates for complete surgery. Each participant will spend 6 months receiving chemoth…
Matched conditions: GASTROINTESTINAL NEOPLASMS
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC